Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BMY - Replimune down as FDA's top cancer drug regulator reportedly intervened in drug rejection

BMY - Replimune down as FDA's top cancer drug regulator reportedly intervened in drug rejection

Bristol-Myers Squibb Company

2025-08-04 06:57:54 ET

More on Replimune Group

For further details see:

Replimune down as FDA’s top cancer drug regulator reportedly intervened in drug rejection

Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com
Menu
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...